Today's Vision Fuqua

https://scitechdaily.com/first-ever-treatment-for-rare-eye-disease-wins-fda-approval-after-landmark-trials/?fbclid=IwVERDUAMcuOJleHRuA2FlbQIxMAABHj-VLncRr_tgk2hjlldMYnxe7IkxAyq6m2pVS7EcSj0o2qmdyyzpFUTx_bVg_aem_JqrVCc6tzLG-WiVJIPl_qA

First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first cell-based treatment for the neurodegenerative retinal disease known as MacTel. For individuals with macular telangiectasia type 2 (MacTel), a rare retinal disease that steadily

Update for Wednesday July 10th. Our office is still without power. We will be closed today. Stay safe.